Veracyte, Inc.
VERACYTE, INC. (Form: 8-K, Received: 06/06/2017 16:20:03)







UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 6, 2017

VERACYTE, INC.
(Exact name of registrant as specified in its charter)

DELAWARE
 
001-36156
 
20-5455398
(State or other jurisdiction of
incorporation)
 
Commission File Number
 
(IRS Employer Identification
No.)

6000 Shoreline Court, Suite 300, South San Francisco, California
 
94080
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (650) 243-6300

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x  









Item 5.07 Submission of Matters to a Vote of Security Holders.

The following actions were taken at the Annual Meeting of Stockholders of Veracyte, Inc., held on June 6, 2017:

1.
The following Class I Directors were elected to serve until the 2020 Annual Meeting of Stockholders or until their successors are duly elected and qualified:

 
For
 
Withheld
 
Broker Non-Votes
Bonnie H. Anderson
29,748,620

 
487,396

 
1,974,587

Robert S. Epstein
28,366,435

 
1,869,581

 
1,974,587

Evan Jones
23,034,675

 
7,201,341

 
1,974,587





2.
The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2017 was approved:

For
 
Against
 
Abstain
32,207,194

 
3,404

 
5








SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Dated: June 6, 2017
 
 
 
 
 
 
VERACYTE, INC.
 
 
 
 
By:
/s/ Keith S. Kennedy
 
Name:
Keith S. Kennedy
 
Title:
Chief Financial Officer
 
 
(Principal Financial and Accounting Officer)